Emerging technologies in autoantibody testing for rheumatic diseases

Testing for the presence of antinuclear antibodies (ANAs) is a key step in the diagnosis of systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases (SARD). The standard slide-based indirect immunofluorescence (IIF) test is widely used, but is limited by a relative lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Nancy J., Choi, May Y., Fritzler, Marvin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525353/
https://www.ncbi.nlm.nih.gov/pubmed/28738887
http://dx.doi.org/10.1186/s13075-017-1380-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525353/
https://www.ncbi.nlm.nih.gov/pubmed/28738887
http://dx.doi.org/10.1186/s13075-017-1380-3

Ejemplares similares